QUIA.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:29):

Stats
Dzisiejszy wolumen	2.85M
Średni wolumen	1.66M
Kapitalizacja rynkowa	6.15M
EPS	SEK-1.220 ( 2022-12-31 )
Następna data zysków	( SEK0 ) 2024-06-14
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.67
ATR14	SEK0.00200 (2.50%)

Wolumen Korelacja

Długi: -0.14 (neutral)

Krótki: 0.26 (neutral)

Signal:(58.129) Neutral

QuiaPEG Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

QuiaPEG Pharmaceuticals Korelacja - Waluta/Towar

-0.44
( neutral )

-0.32
( neutral )

0.00
( neutral )

0.09
( neutral )

QuiaPEG Pharmaceuticals Finanse

Annual	2023
Przychody:	SEK4.37M
Zysk brutto:	SEK2.29M (52.42 %)
EPS:	SEK-0.0335

FY	2023
Przychody:	SEK4.37M
Zysk brutto:	SEK2.29M (52.42 %)
EPS:	SEK-0.0335

FY	2022
Przychody:	SEK5.57M
Zysk brutto:	SEK8.91M (159.81 %)
EPS:	SEK-6.80

FY	2021
Przychody:	SEK0.00
Zysk brutto:	SEK311 000 (0.00 %)
EPS:	SEK-0.320

Financial Reports:

No articles found.

QuiaPEG Pharmaceuticals

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.